Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Danish drugmaker H. Lundbeck will eliminate a total of 50 positions at its research centers in Denmark and the U.S. as part of a refocusing of its R&D strategy. The company, which specializes in brain diseases, says its research will increasingly be based on the relationship between the biology of a disease and its symptoms. It adds that partnerships with universities and other companies, already important, will receive even higher priority in the future.
This article has been sent to the following recipient: